Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Novartis
Novartis
University of California, San Francisco
University of California, San Francisco
Novartis
VA Office of Research and Development
Sirtex Medical
Advanced Accelerator Applications
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
Fred Hutchinson Cancer Center
Novartis
Milton S. Hershey Medical Center
Rush University Medical Center
AbbVie
Montefiore Medical Center
GlaxoSmithKline
Mayo Clinic
Cedars-Sinai Medical Center
Des Moines University
Ain Shams University
Guerbet
Pfizer
Hoffmann-La Roche
VA Office of Research and Development
Mount Carmel Health System
University of Kansas Medical Center
Qidong Gaitianli Medicines Co., Ltd
Temple University
Massachusetts General Hospital
Guerbet
Hoffmann-La Roche
Herlev Hospital
Massachusetts General Hospital
Hoffmann-La Roche
VA Palo Alto Health Care System
University of Ulm
M.D. Anderson Cancer Center
Hoffmann-La Roche
Fox Chase Cancer Center
Mayo Clinic
Pfizer
CSA Medical, Inc.
Kaohsiung Veterans General Hospital.
Hoffmann-La Roche
Hoffmann-La Roche
Cheju Halla General Hospital
Medtronic - MITG
University of Florida
Maastricht University Medical Center
St John of God Hospital, Vienna